Skip to main content
Myla Goldman, MD, Neurology, Richmond, VA

Myla Denise Goldman MD MSc

Neuroimmunology/Multiple Sclerosis


Professor, Department of Neurology, Virginia Commonwealth University

Join to view full profile
  • VCU Department of NeurologyRichmond, VA 23298

  • Phone+1 804-827-1504

Dr. Goldman is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Virginia Medical Center
    University of Virginia Medical CenterResidency, Neurology, 2000 - 2003
  • Rush University Medical Center
    Rush University Medical CenterInternship, Internal Medicine, 1999 - 2000
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1999

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2006 - 2026
  • OH State Medical License
    OH State Medical License 2003 - 2007
  • IL State Medical License
    IL State Medical License 1999 - 2000
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis  
    Myla D Goldman, Amit Bar-Or, JAMA Neurology

Authored Content

  • Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients with Relapsing-Remitting Multiple SclerosisAugust 2020

Press Mentions

  • The Multiple Sclerosis Clinic(s) and Research at UVA
    The Multiple Sclerosis Clinic(s) and Research at UVAApril 4th, 2018
  • Multiple Sclerosis: Smoking After Diagnosis Linked to Disease Progression
    Multiple Sclerosis: Smoking After Diagnosis Linked to Disease ProgressionSeptember 9th, 2015
  • Quitting Smoking After MS Diagnosis May Delay Disease Progression
    Quitting Smoking After MS Diagnosis May Delay Disease ProgressionSeptember 8th, 2015

Grant Support

  • Improving Disease-Modifying Therapy Uptake among Patients with Multiple SclerosisUNIVERSITY OF KENTUCKY2026–2030

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: